Alnylam

The J.P. Morgan Healthcare Confab Monday Morning News Dump
TheStreet.com
Mon, 01/13/14 - 10:12 am
JPMHC 2014
GSK
Intercept Pharma
Acorda Therapeutics
Cell Therapeutics
Novartis
Sanofi
Alnylam
Idenix
Alexion
Galena Biopharma
Incyte
Clovis Oncology
Dendreon
Merck
Arena Pharmaceuticals
Sanofi Pays $700 Million for Alnylam Drugs and Stake
Bloomberg
Mon, 01/13/14 - 08:47 am
Sanofi
Alnylam
Patisiran
Alnylam Pharmaceuticals, Inc.: The Best Performing Biotechs of 2013
Motley Fool
Thu, 12/26/13 - 01:52 pm
RNAi
Alnylam
Alnylam Pharmaceuticals, Inc.: The Best Performing Biotechs of 2013
Motley Fool
Thu, 12/26/13 - 01:51 pm
Alnylam
RNAi
Biggest Winners in Biotech This Year
Motley Fool
Tue, 12/10/13 - 09:14 am
Acadia
Puma Biotechnology
Alnylam
Celldex Therapeutics
Alnylam earns $7M payment for patisiran Phase II 'success'
The Fly on the Wall
Mon, 11/25/13 - 10:44 am
Alnylam
Patisiran
Genzyme
Sanofi
Alnylam rises as FDA bestows fast-track status
Yahoo/AP
Mon, 11/11/13 - 02:13 pm
fast track
Alnylam
FDA
Patisiran
Alnylam Reports Positive Phase II Data for Patisiran (ALN-TTR02), an RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of TTR-Mediated Amyloidosis (ATTR), and Initiates Phase III Trial
Yahoo/BusinessWire
Sun, 11/10/13 - 01:08 pm
Alnylam
Patisiran
amyloidosis
TTR-mediated amyloidosis
Alnylam 4Q loss widens on fewer drug partnerships
Yahoo/AP
Thu, 11/7/13 - 08:13 am
Alnylam
earnings
This New Cholesterol Treatment Has Blockbuster Potential
Motley Fool
Tue, 10/15/13 - 10:09 am
Alnylam
gene silencing
Pfizer
statins
ALN-PCS
Alnylam advances Development Candidate for ALN-AS1
Yahoo/Fly on the Wall
Tue, 10/8/13 - 08:43 am
Alnylam
ALN-AS1
hepatic porphyrias
New Type of Drug to Lower LDL Looks Promising
Med Page Today
Thu, 10/3/13 - 11:33 am
LDL cholesterol
Alnylam
PCSK9 inhibitors
Alnylam's Biggest Opportunities
Motley Fool
Wed, 10/2/13 - 10:02 am
Alnylam
RNAi
ATTR
hemophilia
porphyria
3 Promising Stocks Targeting CTGF and Dermal Scarring
Wall St Cheat Sheet
Sat, 09/14/13 - 10:56 am
dermal scarring
RXI-109
Alnylam
Pfizer
RXi Pharmaceuticals
EXC-001
ALN-TTR02
Alnylam Targets New Highs On Data Supporting RNAi
Seeking Alpha
Sat, 07/20/13 - 11:18 am
RNA interference
Alnylam
The Best- And Worst-Performing Biotech Stocks July 5 To July 12
Forbes
Mon, 07/15/13 - 11:58 am
Vivus
Trius Therapeutics
Prosensa
Pharmacyclics
NxStage Medical
Natus Medical
MiMedx
Merrimack Pharmaceuticals
Intuitive Surgical
InterMune
GTx
Fluidigm
Epizyme
Celldex
Astex
Analogic
Amarin
Alnylam
Alexion
AcelRx
This Week in Biotech
Motley Fool
Sun, 07/14/13 - 11:19 am
Pharmacyclics
JNJ
Alnylam
Inovio
Alexion
Roche
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 07/13/13 - 11:46 am
Prosensa
Alnylam
Web MD
Alnylam Soars To New High On Early Drug Trial Results
Investors.com
Fri, 07/12/13 - 07:32 am
Alnylam
RNAi
ALN-TTRsc
The Best- And Worst-Performing Biotech Stocks, June 28 to July 5
Forbes
Mon, 07/8/13 - 11:02 am
biotech
ONYX Pharmaceuticals
Celldex
Novavax
Puma Biotechnology
Endocyte
Alnylam
Bluebird Bio
Dyax
Medivation
Clovis Oncology
Achillion
Insmed
Arena Pharmaceuticals
Avanir
Receptos
Synergy Pharmaceuticals
ChemoCentryx
Idenix
MiMedx
Portola Pharmaceuticals

Pages